West Nile Detect™ IgM Capture ELISA - FDA cleared


InBios' West Nile Detect™ IgM Capture ELISA is for the qualitative presumptive detection of IgM antibodies to WNV recombinant antigens (WNRA) in serum as an aid in the clinical laboratory diagnosis of West Nile virus infection in patients with clinical symptoms consistent with encephalitis/meningitis.

Positive results must be confirmed by Plaque Reduction Neutralization Test (PRNT), or by using the current CDC guidelines for diagnosis of this disease.

Features Sensitivity and specificity > 95%. Easy to follow protocol. Results in 4 hours or less. Excellent correlation with PRNT and CDC ELISA


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : InBios International Inc. View Company Information

Posted on February 21, 2005








Get our eNewsletter
Over 6,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS